{
  "drugs": [
    {
      "drug": "VS-7375",
      "proteins": [
        "KRAS"
      ],
      "mechanism": "KRAS G12D ON/OFF inhibitor",
      "fda_status": "Fast Track (PDAC)",
      "category": "mainstream"
    },
    {
      "drug": "Daraxonrasib",
      "proteins": [
        "KRAS"
      ],
      "mechanism": "RAS(ON) multi-selective inhibitor",
      "fda_status": "Breakthrough Therapy (PDAC)",
      "category": "mainstream"
    },
    {
      "drug": "ASP3082",
      "proteins": [
        "KRAS"
      ],
      "mechanism": "KRAS G12D degrader",
      "fda_status": "Preclinical",
      "category": "mainstream"
    },
    {
      "drug": "RP03707",
      "proteins": [
        "KRAS"
      ],
      "mechanism": "Selective KRAS G12D inhibitor",
      "fda_status": "Preclinical",
      "category": "mainstream"
    },
    {
      "drug": "Tipifarnib",
      "proteins": [
        "KRAS"
      ],
      "mechanism": "Farnesyltransferase inhibitor",
      "fda_status": "Phase II failure",
      "category": "mainstream"
    },
    {
      "drug": "Disulfiram",
      "proteins": [
        "KRAS"
      ],
      "mechanism": "Inhibits KRAS-driven proliferation via disulfiram-copper complex",
      "fda_status": "FDA-approved for alcohol use disorder",
      "category": "repurposing_candidate"
    },
    {
      "drug": "Metformin",
      "proteins": [
        "KRAS"
      ],
      "mechanism": "Suppresses KRAS-mutant tumor growth by activating AMPK",
      "fda_status": "FDA-approved for type 2 diabetes",
      "category": "repurposing_candidate"
    },
    {
      "drug": "Simvastatin",
      "proteins": [
        "KRAS"
      ],
      "mechanism": "Blocks prenylation of KRAS",
      "fda_status": "FDA-approved for hypercholesterolemia",
      "category": "repurposing_candidate"
    },
    {
      "drug": "Propranolol",
      "proteins": [
        "CD44"
      ],
      "mechanism": "Disrupts CD44-HA interactions",
      "fda_status": "FDA-approved for hypertension",
      "category": "repurposing_candidate"
    },
    {
      "drug": "Itraconazole",
      "proteins": [
        "KRAS"
      ],
      "mechanism": "Inhibits KRAS-dependent hedgehog signaling",
      "fda_status": "FDA-approved for fungal infections",
      "category": "repurposing_candidate"
    },
    {
      "drug": "Aspirin",
      "proteins": [
        "KRAS"
      ],
      "mechanism": "Inhibits PGE2-mediated KRAS activation",
      "fda_status": "FDA-approved for anti-inflammatory use",
      "category": "repurposing_candidate"
    },
    {
      "drug": "Thioridazine",
      "proteins": [
        "CD44"
      ],
      "mechanism": "Targets CD44+ cancer stem cells",
      "fda_status": "FDA-approved for schizophrenia",
      "category": "repurposing_candidate"
    },
    {
      "drug": "Cimetidine",
      "proteins": [
        "CD44"
      ],
      "mechanism": "Inhibits CD44-mediated leukocyte adhesion",
      "fda_status": "FDA-approved for peptic ulcers",
      "category": "repurposing_candidate"
    },
    {
      "drug": "Verapamil",
      "proteins": [
        "KRAS"
      ],
      "mechanism": "Inhibits calcium-dependent KRAS membrane trafficking",
      "fda_status": "FDA-approved for hypertension",
      "category": "repurposing_candidate"
    },
    {
      "drug": "Chloroquine",
      "proteins": [
        "KRAS"
      ],
      "mechanism": "Promotes autophagic clearance of oncogenic KRAS",
      "fda_status": "FDA-approved for malaria",
      "category": "repurposing_candidate"
    }
  ],
  "cancer_type": "pancreatic cancer",
  "protein_targets": [
    "KRAS",
    "CD44"
  ]
}